Nanjing Vazyme Biotech Co Ltd
SSE:688105
Nanjing Vazyme Biotech Co Ltd
Cash from Investing Activities
Nanjing Vazyme Biotech Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nanjing Vazyme Biotech Co Ltd
SSE:688105
|
Cash from Investing Activities
-¥900.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
N/A
|
Beigene Ltd
HKEX:6160
|
Cash from Investing Activities
¥117.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Investing Activities
-¥998.7m
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Investing Activities
-¥942.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-14%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Investing Activities
-¥943.7m
|
CAGR 3-Years
-233%
|
CAGR 5-Years
-143%
|
CAGR 10-Years
N/A
|
See Also
What is Nanjing Vazyme Biotech Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-900.7m
CNY
Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Cash from Investing Activities amounts to -900.7m CNY.
What is Nanjing Vazyme Biotech Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-74%
Over the last year, the Cash from Investing Activities growth was 5%. The average annual Cash from Investing Activities growth rates for Nanjing Vazyme Biotech Co Ltd have been 1% over the past three years , -74% over the past five years .